Full-Time

Manager/Senior Manager

Posted on 4/18/2024

Corcept Therapeutics

Corcept Therapeutics

201-500 employees

Develops cortisol modulation technologies for diseases

Biotechnology

Compensation Overview

$145,000 - $205,000Annually

Senior

Menlo Park, CA, USA

Required Skills
Communications
Word/Pages/Docs
PowerPoint/Keynote/Slides
Requirements
  • Experience with Veeva Vault systems
  • Detail oriented with excellent oral and written communication skills
  • Strong team player, self-motivated and able to function independently as well as part of a team
  • Able to work on multiple projects concurrently and adapt to a continuously changing environment
  • Proficient in organization, prioritization, and time management
  • Experience with Microsoft Word, PowerPoint and Excel
  • BA/BS degree in a scientific discipline
  • 5+ years' experience in the pharmaceutical industry or life sciences with 4+ years of regulatory experience
Responsibilities
  • Maintaining the Veeva Vault RIM system and ensuring that all regulatory records are up to date
  • Managing the change control process in Veeva Vault RIM
  • Maintaining the Regulatory shared drive and ensuring that all US/ex-US submissions and correspondence files are up to date
  • Collaborating with the external publishing vendor for e-submission files and submission receipts
  • Managing the spreadsheet that lists all weekly/monthly regulatory submissions and communicates the information with the external publishing vendor
  • Maintaining templates and style guides for regulatory submissions
  • Working closely with other members of the Regulatory team and provide support to their projects as needed
  • Participating in the development of standard operating procedures

Corcept Therapeutics specializes in developing selective glucocorticoid receptor antagonists to address the adverse effects of excess cortisol in a range of diseases, with a primary emphasis on creating a new generation of compounds aimed at mitigating the effects of excess cortisol in various diseases. Their focus is on cortisol modulation technologies for endocrine, metabolic, oncologic, and psychiatric disorders, with a pipeline of over 30 ongoing studies.

Company Stage

IPO

Total Funding

$119.1M

Headquarters

Menlo Park, California

Founded

1998

Growth & Insights
Headcount

6 month growth

8%

1 year growth

15%

2 year growth

38%